Your trusted source for investing success

Tag: Chief Executive Officer

NeuroMetrix and GlaxoSmithKline will Collaborate to Develop and Expand Access to Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (Nasdaq:NURO) announced today a collaboration with GlaxoSmithKline (NYSE:GSK), one of the world’s largest science-led global healthcare companies, involving Quell® Wearable Pain Relief Technology™.

As quoted in the press release:
“We are excited by the opportunity to partner with GSK Consumer Healthcare to expand access to Quell technology among chronic pain sufferers around

Strongbridge Biopharma Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris

Strongbridge Biopharma (NASDAQ:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that the Company has acquired the U.S. and Canadian rights to MACRILEN™ (macimorelin) from Aeterna Zentaris Inc. (NASDAQ:AEZS).

As quoted from the press release:
“We are extremely

Harvest One Announces Filing of Preliminary Short Form Prospectus in Connection with $35 Million Bought Deal Financing and Appointment of Interim COO

Harvest One Announces Filing of Preliminary Short Form Prospectus in Connection with $35 Million Bought Deal Financing and Appointment of Interim COO

Harvest One Cannabis Inc. (TSX VENTURE:HVST) (“Harvest One” or the “Company”) is pleased to announce that it has filed a preliminary short form prospectus in each of the provinces of Canada (except Quebec), and obtained a receipt from the British Columbia Securities Commission to qualify the distribution of $35,000,000 of

Cache Exploration Closes Non-Brokered Private Placement

Cache Exploration Closes Non-Brokered Private Placement

Cache Exploration Inc. (the “Company”, or “Cache”), (TSX-V:CAY) announces that it has closed its previously announced financing raising an aggregate of $738,600, through the sale of 9,232,500 units at $0.08 comprised of one common share and one common share purchase warrant at $0.10 per share for two years from closing.

Cypress to Attend 2018 Vancouver Resource Investment Conference

Cypress to Attend 2018 Vancouver Resource Investment Conference

Cypress Development Corp. (TSX-V: CYP) (OTCBB: CYDVF) (Frankfurt: C1Z1) (“Cypress” or the “Company”) is pleased to invite shareholders and the investment community to the Cambridge 2018 Vancouver Resource Investment Conference, the world’s largest resource investment conference dedicated to resource exploration, on January 21st and 22nd at the Vancouver Convention Centre

Pediapharm Begins Trading on the OTCQB Venture Market

Pediapharm (TSXV:PDP) is pleased to announce the Company’s common shares begin trading today on the OTCQB Venture Market in the United States under the symbol “PDDPF”.

As quoted in the press release:
“Getting listed on the OTCQB is part of our strategy to introduce Pediapharm to a wider audience,” stated Sylvain Chretien,

Longblockchain Enters into Letter-of-intent with Stater Blockchain

Long Blockchain (NASDAQCM:LBCC) has announced it has entered into a letter of intent with Stater Blockchaion, a company focused on developing and deploying globally-scalable blockchain technology solutions in the financial industry.

As quoted in the press release:
Stater’s wholly-owned subsidiary, Stater Global Markets, is a Financial Conduct Authority (FCA) regulated brokerage that facilitates market

First Cobalt Announces $7 Million Exploration Program for 2018

First Cobalt Corp. (TSX-V: FCC, ASX: FCC, OTCQB: FTSSF) (the “Company”) is pleased to announce its 2018 exploration program for its Cobalt Camp properties in Ontario, Canada. The C$7 million program includes over 26,000m of drilling on 13 different targets.

As quoted in the press release:

Trent Mell, President & Chief Executive Officer, commented:
“Having consolidated the Cobalt

Mandalay Resources Announces Production and Sales Results for the Fourth Quarter and Full Year 2017, Provides Production and Cost Guidance for 2018

Mandalay Resources (“Mandalay” or the “Company”) (TSX:MND) announced today its production and sales results for the fourth quarter of 2017.

In the fourth quarter of 2017, Mandalay produced a consolidated 34,395 saleable ounces of gold equivalent and sold 29,547 ounces of gold equivalent. For the full year ended December 31, 2017,

Ackroo Announces 23 Percent Year over Year Revenue Growth for 2017

Ackroo (TSXV:AKR) has announced unaudited record revenue of $2.74 million for the year-end of December 2017.

As quoted in the press release:
This represents a 23% increase over the previous year and a 5 year cumulative average growth rate of 35% per year since the Company’s founding in 2012. The Company also

YDreams Global Signs Deal With Major Sponsor for New Project

YDreams Global Signs Deal With Major Sponsor for New Project

YDreams Global Interactive Technologies Inc. (TSXV:YD, OTC Pink: YDRMF, FSE: A2AP0L) (“YDreams Global” or the “Company) would like to announce that it has signed on for a new project entitled “Social Media Influencers – Game Edition”, with the first sponsor of an interactive exhibition that will take place in nine

Tech Forecast and Promising Tech Stocks To Buy in 2017

Learn about breakthrough technology about to impact lives around the globe. We cover the entire industry in our FREE investor’s report.   Gain Access
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
NeuroMetrix and GlaxoSmithKline will Collaborate to Develop and Expand Access to Quell Wearable Pain Relief Technology

URL: https://investingnews.com/daily/life-science-investing/medical-device-investing/neurometrix-glaxosmithkline-will-collaborate-develop-expand-access-quell-wearable-pain-relief-technology/